164 related articles for article (PubMed ID: 18497549)
1. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
[TBL] [Abstract][Full Text] [Related]
2. The role of preoperative serum cancer antigen 125 in malignant ovarian germ cell tumors.
Kim JH; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
Taiwan J Obstet Gynecol; 2018 Apr; 57(2):236-240. PubMed ID: 29673667
[TBL] [Abstract][Full Text] [Related]
3. Ovarian germ cell tumours: a 17-year study in a single unit.
Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
[TBL] [Abstract][Full Text] [Related]
4. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
[TBL] [Abstract][Full Text] [Related]
5. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
6. Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome.
Taskinen S; Fagerholm R; Lohi J; Taskinen M
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):425-9. PubMed ID: 25640522
[TBL] [Abstract][Full Text] [Related]
7. Significance of cyclin E and p27 expression in malignant ovarian germ cell tumors: correlation with the cell proliferation activity and clinicopathologic features.
Kawauchi S; Yamamoto Y; Uchida K; Chochi Y; Kondo T; Oga A; Sasaki K
Oncol Rep; 2006 Nov; 16(5):1029-33. PubMed ID: 17016588
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary.
Trinh DT; Shibata K; Hirosawa T; Umezu T; Mizuno M; Kajiyama H; Kikkawa F
J Obstet Gynaecol Res; 2012 May; 38(5):841-8. PubMed ID: 22448662
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.
Chang MC; Vargas SO; Hornick JL; Hirsch MS; Crum CP; Nucci MR
Int J Gynecol Pathol; 2009 Jul; 28(4):347-55. PubMed ID: 19483629
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors.
Pauls K; Jäger R; Weber S; Wardelmann E; Koch A; Büttner R; Schorle H
Int J Cancer; 2005 Jun; 115(3):470-7. PubMed ID: 15700319
[TBL] [Abstract][Full Text] [Related]
12. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features.
Shaaban AM; Rezvani M; Elsayes KM; Baskin H; Mourad A; Foster BR; Jarboe EA; Menias CO
Radiographics; 2014; 34(3):777-801. PubMed ID: 24819795
[TBL] [Abstract][Full Text] [Related]
13. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
Zhang M; Jiang W; Li G; Xu C
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
[TBL] [Abstract][Full Text] [Related]
14. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers.
Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF
Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358
[TBL] [Abstract][Full Text] [Related]
16. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.
Iczkowski KA; Butler SL; Shanks JH; Hossain D; Schall A; Meiers I; Zhou M; Torkko KC; Kim SJ; MacLennan GT
Hum Pathol; 2008 Feb; 39(2):275-81. PubMed ID: 18045648
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
[TBL] [Abstract][Full Text] [Related]
18. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
19. The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Kaern J; Flørenes VA; Kopolovic J; Tropé CG; Abeler VM; Reich R; Davidson B
Gynecol Oncol; 2006 Mar; 100(3):462-8. PubMed ID: 16216317
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein in germ cell tumors. An immunohistochemical study.
Chaudhary RK; Kher A; Bobhate SK; Grover S
Indian J Pathol Microbiol; 1989 Jul; 32(3):167-73. PubMed ID: 2476392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
